Lepra vaccine: Misinterpreted myth

International Journal of Dermatology

Volumn 45, Issue 2, 2006, Pages 164-167

  Sehgal, Virendra N ^a,b   Sardana, Kabir ^a,b  

^a Sehgal Nursing Home   (India)

^b LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; INACTIVATED VACCINE; LEPROSY VACCINE; MYCOBACTERIUM VACCINE; MYCOBACTERIUM WELCHII VACCINE; PLACEBO; SODIUM CHLORIDE; STEROID; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DRUG EFFICACY; ERADICATION THERAPY; ERYTHEMA NODOSUM LEPROSUM; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTERMETHOD COMPARISON; LEPROSY; LITERATURE; MYCOBACTERIUM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM WELCHII; NOTE; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; TREATMENT OUTCOME;

BACTERIAL VACCINES; CLINICAL TRIALS; HUMANS; LEPROSY; MYCOBACTERIUM LEPRAE;

EID: 33646000590     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02428.x     Document Type: Note

References (19)

1. Sehgal VN. Clinical Leprosy, 4th edn. New Delhi, India: JP Brothers, 2004; 178.
2. Whitty C. Mycobacterium w immunotherapy in leprosy. Lepr Rev 1998; 69: 222-224.
3. Brown JA, Stone MM, Sutherland I. BCG vaccination of children against leprosy in Uganda: Results at end of second follow-up. Br Med J 1968; 1: 24-27.
4. Lwin K, Sundaresan T, Gyi MM, et al. BCG vaccination of children against leprosy: Fourteen-year findings of the trial in Burma. Bull World Health Organ 1985; 63: 1069-1078.
5. Bagshawe A, Scott GC, Russell DA, et al. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79. Bull World Health Organ 1989; 67: 389-399.
6. Gupte MD, Vallishayee RS, Anantharaman DS, et al. Comparative leprosy vaccine trial in south India. Indian J Lepr 1998; 70: 369-388.
7. Karonga Prevention Trial Group. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 1996; 348: 17-24.
8. Convit J, Uhlrich M. Immunotherapy and immunoprophylaxis of leprosy. Ind J Lper 2000; 72: 21-34.
9. Sehgal VN, Srivastava G, Sharma VK. Contemplative immune mechanism of Lucio phenomenon and its global status. J Dermatol (Tokyo) 1987; 14: 580-585.
10. Zaheer SA, Beena KR, Kar HK, et al. Addition of immunotherapy with Mycobactreium w vaccine to multidrug therapy benefits multibacillary patients. Vaccine 1995; 13: 1102-1110.
11. Gupte MD. South India immunoprophylaxis trial against leprosy: Relevance of findings in the context of leprosy trends. Int J Lepr Other Mycobact Dis 2001,69: 10-13.
12. Bhattacharya SN, Sehgal VN. An re-appraisal of drifting scenario of leprosy multi-drug therapy (MDT): A proposal for fresh approach in the new millennium. Int J Dermatol 2002; 41: 321-326.
13. Kaur I, Dogra S, Kumar B, et al. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: A follow-up of 136 patients. Int J Lepr Other Mycobact Dis 2002; 70: 174-181.
14. Sehgal VN. Reactions in leprosy -clinical aspects. Int J Dermatol 1987; 26: 278-285.
15. Sehgal VN, Gautam RK, Sharma VK. Immunoprofile of reaction in leprosy. Int J Dermatol 1986; 25: 240-244.
16. Sehgal VN, Sharma V. Reactions in leprosy -a prospective study of clinical, bacteriological, immunological and histopathological parameters in thirty-five Indians. J Dermatol (Tokyo) 1988; 15: 412-419.
17. Sehgal VN, Srivastava G, Sundharam JA. Immunology of reactions in leprosy. Int J Dermatol 1988; 27: 396-399.
18. Anonymous WHO Expert Committee on Leprosy. 7th Report. Technical Report Series 874. Geneva: WHO, 1998.
19. Sehgal VN, Sardana K. Lepra vaccine. Skin Med 2004; 3: 167-168.